ADC Therapeutics SA

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: ADC Therapeutics SA
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Switzerland
Headquarters city: Epalinges
Headquarters country: Switzerland
Fiscal year end: December
Ticker symbol: ADCT
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001771910

Board of directors

Follow this board

Ameet Mallik · Director · Chief Executive Officer
Since 2024
Jean-Pierre Bizzari · Director
Since 2024
Peter Hug · Director
Since 2024
Robert Azelby · Director
Since 2024
Ron Squarer · Director
Since 2024
Thomas Pfisterer · Director
Since 2024
Timothy Coughlin · Director Overboarded
Since 2025
Tyrell Rivers · Director
Since 2024
Victor Sandor · Director
Since 2024
Viviane Monges · Director
Since 2024

Chief executives

Ameet Mallik · Chief Executive Officer

Since January 2024

76 CEO score

Strong · grade B

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 76

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Director election results

Annual meeting of June 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 14 other boards. 14 are in the same sector.

Shared director Other board Same sector

Travere Therapeutics Inc. Same sector
via Ron Squarer and Timothy Coughlin
AbCellera Biologics Inc. Same sector
via Victor Sandor
Aprea Therapeutics Inc. Same sector
via Jean-Pierre Bizzari
Atara Biotherapeutics Inc. Same sector
via Ameet Mallik
Autolus Therapeutics plc American Depositary Share Same sector
via Robert Azelby
Cardinal Health Inc. Same sector
via Robert Azelby
Fate Therapeutics Inc. Same sector
via Timothy Coughlin
Halozyme Therapeutics Inc. Same sector
via Jean-Pierre Bizzari
Kymera Therapeutics Inc. Same sector
via Victor Sandor
Pharvaris N.V. Same sector
via Viviane Monges
Prelude Therapeutics Incorporated Same sector
via Victor Sandor
Tango Therapeutics Inc. Same sector
via Robert Azelby
Vir Biotechnology Inc. Same sector
via Timothy Coughlin
aTyr Pharma Inc. Same sector
via Timothy Coughlin

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $19,641,067; 6 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Jun 30, 2026	Ameet Mallik Director, Officer (Chief Executive Officer)	Grant or award	+675,000	—	—
Jun 30, 2026	Carmona Jose Officer (Chief Financial Officer)	Grant or award	+203,700	—	—
Jun 30, 2026	GRAHAM PETER J Officer (Chief Legal Officer)	Grant or award	+221,100	—	—
Jun 30, 2026	Zaki Mohamed Officer (Chief Medical Officer)	Grant or award	+213,900	—	—
Jun 3, 2026	Robert Azelby Director	Shares withheld for tax	−12,600	$3.08	$38,808
Jun 3, 2026	Ron Squarer Director	Shares withheld for tax	−15,196	$3.08	$46,804
Jun 3, 2026	Victor Sandor Director	Shares withheld for tax	−12,600	$3.08	$38,808
Jun 3, 2026	Viviane Monges Director	Shares withheld for tax	−2,596	$3.08	$7,996
Jun 3, 2026	Peter Hug Director	Shares withheld for tax	−2,156	$3.08	$6,640
Jun 3, 2026	Jean-Pierre Bizzari Director	Shares withheld for tax	−12,600	$3.08	$38,808
Jun 3, 2026	Timothy Coughlin Director	Shares withheld for tax	−12,600	$3.08	$38,808
Jun 1, 2026	Robert Azelby Director	Grant or award	+45,000	—	—
Jun 1, 2026	Ron Squarer Director	Grant or award	+45,000	—	—
Jun 1, 2026	Victor Sandor Director	Grant or award	+45,000	—	—
Jun 1, 2026	Viviane Monges Director	Grant or award	+45,000	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

AC Immune SA Nasdaq: ACIU · 1015 Lausanne, Switzerland Organization Addex Therapeutics Ltd Nasdaq: ADXN · Geneva, Switzerland Organization Alcon Inc. NYSE: ALC · Fort Worth, Switzerland Organization Novartis AG NYSE: NVS · Basel, Switzerland Organization

Questions about ADC Therapeutics SA

Who is the CEO of ADC Therapeutics SA?

Ameet Mallik has been ADC Therapeutics SA's Chief Executive Officer since January 2024.

How many directors are on ADC Therapeutics SA's board?

ADC Therapeutics SA's board has 10 directors: Ameet Mallik, Jean-Pierre Bizzari, Peter Hug, Robert Azelby, Ron Squarer, Thomas Pfisterer, Timothy Coughlin, Tyrell Rivers, Victor Sandor and Viviane Monges.

Are ADC Therapeutics SA insiders buying or selling shares?

Over the last 12 months, ADC Therapeutics SA insiders made no open-market purchases and sold $19.6 million of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is ADC Therapeutics SA connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="adc-therapeutics-sa"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.